Estrogen Replacement Therapy
-
Subject Areas on Research
-
A path model of chronic stress, the metabolic syndrome, and coronary heart disease.
-
A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease.
-
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
-
Active lifestyle offsets HRT-induced suppression of T cell reactivity to mitogens.
-
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.
-
Benefits and drawbacks to hormone replacement therapy among nursing home patients.
-
Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease.
-
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
-
Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein.
-
DNA repair and epidemiology of basal cell carcinoma.
-
DNA repair related to multiple skin cancers and drug use.
-
Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife.
-
Differences in brain volumes among males and female hormone-therapy users and nonusers.
-
Differences in providers' beliefs about benefits and risks of hormone replacement therapy in managed care.
-
Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use.
-
Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE)
-
Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia.
-
Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy.
-
Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.
-
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored.
-
Estrogen effects on cognition across the lifespan.
-
Estrogen, estrogen plus progestin therapy, and risk of breast cancer.
-
Evaluating participants' use of a hormone replacement therapy decision-making intervention.
-
Evidence supporting secondary prevention strategies.
-
Exogenous hormone use and meningioma risk: what do we tell our patients?
-
Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females.
-
Focusing on inflammation in the treatment of atherosclerosis.
-
For patients: hormone replacement therapy.
-
Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
-
Gender and heart disease.
-
Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.
-
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.
-
HRT & the World Wide Web. Helping patients find good information on the web.
-
Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy.
-
Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women.
-
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.
-
Hormone replacement therapy and ischemic stroke severity in women: a case-control study.
-
Hormone replacement therapy menopause with a better future--a survey of views on hormone replacement therapy (HRT).
-
Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.
-
Hormone therapy does not affect depression severity in older women.
-
Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.
-
Hormone therapy: physiological complexity belies therapeutic simplicity.
-
Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women.
-
Impact of hormone replacement therapy on exercise training-induced improvements in insulin action in sedentary overweight adults.
-
Implanted estrogen pellets associated with hypertriglyceridemia, biliary dyskinesia and focal nodular hyperplasia of the liver: a case report.
-
Increased blood pressure in mice lacking cytochrome P450 2J5.
-
Initiation and discontinuation of hormone therapy for menopausal symptoms: results from a community sample.
-
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
-
Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms.
-
Menopausal hormones and risk of ovarian cancer.
-
Menopause and mood. Is depression linked with hormone changes?
-
Menostar - a low-dose estrogen patch for osteoporosis.
-
Mesh erosion in abdominal sacral colpopexy with and without concomitant hysterectomy.
-
Mining the complexities of the estrogen signaling pathways for novel therapeutics.
-
Modification of the effects of estrogen therapy on HDL cholesterol levels by polymorphisms of the HDL-C receptor, SR-BI: the Rancho Bernardo Study.
-
Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
-
Perceptions of menopausal stage and patterns of hormone replacement therapy use.
-
Postmenopausal hormone replacement therapy. Information for effective patient counseling.
-
Postmenopausal hormone use in women with acute coronary syndromes.
-
Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
-
Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.
-
Prevention and health services delivery.
-
Primary prevention of stroke.
-
Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
-
Racial differences in tumor grade among women with endometrial cancer.
-
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions.
-
Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation.
-
Selective estrogen receptor modulators (SERMs): A first step in the development of perfect hormone replacement therapy regimen.
-
Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS).
-
Surgical Menopause and Frailty Risk in Community-Dwelling Older Women: Study of Osteoporotic Fractures.
-
The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease.
-
The cardiovascular patient's perceptions of complementary and alternative medicine.
-
The ethics of aggregation and hormone replacement therapy.
-
The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease.
-
The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
-
Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects.
-
Type and duration of exogenous hormone use affects breast cancer histology.
-
Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
-
Update on Alzheimer's disease. Promising advances in detection and treatment.
-
Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms.
-
Why cardiologists should be interested in estrogen.
-
Keywords of People
-
Berchuck, Andrew,
James M. Ingram Distinguished Professor of Gynecologic Oncology,
Obstetrics and Gynecology, Gynecologic Oncology
-
McDonnell, Donald Patrick,
Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology, in the School of Medicine,
Duke Innovation & Entrepreneurship
-
Moorman, Patricia Gripka,
Professor in Family Medicine and Community Health,
Duke Cancer Institute
-
O'Connor, Christopher Michael,
Richard Sean Stack, M.D. Distinguished Professor,
Medicine, Clinical Pharmacology